Cargando…
Liposome Technology for Industrial Purposes
Liposomes, spherical vesicles consisting of one or more phospholipid bilayers, were first described in the mid 60s by Bangham and coworkers. Since then, liposomes have made their way to the market. Today, numerous lab scale but only a few large-scale techniques are available. However, a lot of these...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065896/ https://www.ncbi.nlm.nih.gov/pubmed/21490754 http://dx.doi.org/10.1155/2011/591325 |
_version_ | 1782201034844667904 |
---|---|
author | Wagner, Andreas Vorauer-Uhl, Karola |
author_facet | Wagner, Andreas Vorauer-Uhl, Karola |
author_sort | Wagner, Andreas |
collection | PubMed |
description | Liposomes, spherical vesicles consisting of one or more phospholipid bilayers, were first described in the mid 60s by Bangham and coworkers. Since then, liposomes have made their way to the market. Today, numerous lab scale but only a few large-scale techniques are available. However, a lot of these methods have serious limitations in terms of entrapment of sensitive molecules due to their exposure to mechanical and/or chemical stress. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability. An additional point of view was taken to regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents. |
format | Text |
id | pubmed-3065896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-30658962011-04-13 Liposome Technology for Industrial Purposes Wagner, Andreas Vorauer-Uhl, Karola J Drug Deliv Review Article Liposomes, spherical vesicles consisting of one or more phospholipid bilayers, were first described in the mid 60s by Bangham and coworkers. Since then, liposomes have made their way to the market. Today, numerous lab scale but only a few large-scale techniques are available. However, a lot of these methods have serious limitations in terms of entrapment of sensitive molecules due to their exposure to mechanical and/or chemical stress. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability. An additional point of view was taken to regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents. Hindawi Publishing Corporation 2011 2010-12-05 /pmc/articles/PMC3065896/ /pubmed/21490754 http://dx.doi.org/10.1155/2011/591325 Text en Copyright © 2011 A. Wagner and K. Vorauer-Uhl. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Wagner, Andreas Vorauer-Uhl, Karola Liposome Technology for Industrial Purposes |
title | Liposome Technology for Industrial Purposes |
title_full | Liposome Technology for Industrial Purposes |
title_fullStr | Liposome Technology for Industrial Purposes |
title_full_unstemmed | Liposome Technology for Industrial Purposes |
title_short | Liposome Technology for Industrial Purposes |
title_sort | liposome technology for industrial purposes |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065896/ https://www.ncbi.nlm.nih.gov/pubmed/21490754 http://dx.doi.org/10.1155/2011/591325 |
work_keys_str_mv | AT wagnerandreas liposometechnologyforindustrialpurposes AT voraueruhlkarola liposometechnologyforindustrialpurposes |